Subscribe to Newsletter
Subspecialties Imaging & Diagnostics, Basic & Translational Research

Blood Biomarkers for AMD

Original image from Shutterstock.com

Age-related macular degeneration (AMD) can be challenging to diagnose in its early stages – with a reliance on imaging techniques that is not always effective. Now, researchers of a Journal of Advanced Research study have outlined a new approach for identifying and tracking blood-based metabolic biomarkers for AMD.

Using a multicenter cohort study design, involving 547 participants, and a mass spectrometry-based metabolomic workflow combined with machine learning techniques, the team uncovered three metabolites – hypoxanthine, 2-furoylglycine, and 1-hexadecyl-2-azelaoyl-sn-glycero-3-phosphocholine – that were strongly associated with AMD’s onset, severity, and progression.

The resulting three-biomarker panel demonstrated excellent accuracy in distinguishing AMD patients from healthy controls and individuals with other eye diseases. The study also highlighted that these biomarkers are stable in repeated tests and can withstand multiple freeze-thaw cycles without demonstrating any decrease in their levels, making them reliable candidates for clinical use.

The biomarkers also provided the researchers with insights into the AMD’s severity, allowing them to classify the disease into early, intermediate, and advanced stages, in accordance with the classification system used by the Age-Related Eye Disease Study (AREDS).

According to the authors, “This study reveals distinct metabolite variations in the serum of AMD patients, paving the way for the development of the first routine laboratory test for AMD.”

NEWS

The Ophthalmologist Presents:

The Ophthalmologist Weekly Newsletter

Enjoying yourself? There's plenty more where that came from! Our weekly newsletter from The Ophthalmologist brings you the most popular stories as they unfold, chosen by our fantastic Editorial team!

Register for our weekly newsletter

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
The Ophthalmologist
Related Case Studies
Business & Profession Glaucoma
TrabEx Pro: The Next Level in MIGS

| Contributed by MST

The Missing Piece of the Dry Eye Puzzle

| Contributed by Quidel

Uncovering Ocular Comorbidity

| Contributed by Quidel

Related Product Profiles
Uncover the Unique DNA of SPECTRALIS®

| Contributed by Heidelberg Engineering

Subspecialties Cornea / Ocular Surface
Tear Osmolarity – Empowering. Established. Essential.

| Contributed by TearLab

Subspecialties Retina
ForeseeHome® – remote monitoring to help detect wet AMD earlier and improve outcomes

| Contributed by Notal Vision

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Most Popular
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: